Related Experiment Video
Updated: Jul 10, 2026
09:31
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
Five stages of evolving beta-cell dysfunction during progression to diabetes
Gordon C Weir1, Susan Bonner-Weir
1Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA. gordon.weir@joslin.harvard.edu
Diabetes
|November 25, 2004
Summary
This study outlines five stages of diabetes progression, detailing changes in beta-cell mass and function. Understanding these stages offers new insights into diabetes pathophysiology and remission potential.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Beta-cell Biology
Background:
- Diabetes is characterized by progressive beta-cell dysfunction.
- Existing models lack a clear staging of beta-cell changes during diabetes progression and remission.
Purpose of the Study:
- To propose a five-stage model for diabetes progression based on beta-cell mass, phenotype, and function.
- To elucidate the pathophysiology of diabetes progression and remission.
Main Methods:
- Conceptual framework development based on existing literature.
- Analysis of beta-cell characteristics (mass, phenotype, function) across proposed stages.
Main Results:
- Stage 1: Compensatory hypersecretion of insulin.
- Stage 2: Beta-cell adaptation with mass loss and functional decline.
- Stages 3-5: Increasing decompensation, dedifferentiation, and potential ketosis.
- Reversibility of stages 1-4 observed in type 1 and type 2 diabetes remission.
Conclusions:
- The five-stage model provides a framework for understanding diabetes progression and remission.
- Beta-cell dedifferentiation and mass changes are key indicators across diabetes stages.
- This staging aids in predicting and managing diabetes trajectories.
More Related Videos
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...